Michigan aims to cap lost season by beating Ohio State
Shailene Woodley still cries over ‘toxic’ Aaron Rodgers relationshipNone
The Best Beauty and Self-Care Gifts on Sale During Black Friday
Harvey Arcangeletti of Sault Ste. Marie has been honoured with the Dr. Frank Hayden Athlete Lifetime Achievement Award from Special Olympics Canada for his many accomplishments as a competitor in numerous sports over the course of nearly five decades. The award is bestowed upon an athlete who has “best exemplified the spirit, philosophy and goals of the Special Olympics movement over the course of their career,” according to the Special Olympics Canada website. Arcangeletti was presented with the award during a ceremony held in Toronto Oct. 29. “It was pretty exciting,” he told SooToday during a recent interview. “The medals come second — the skill and the hard work is the goal of it.” The Sault native is a decorated athlete who has earned 105 medals in Special Olympics action — which has seen Arcangeletti compete in swimming, baseball, track, floor hockey and bowling events — since he began participating back in 1976 as a 16-year-old. He has represented Special Olympics Canada at World Games in Baton Rouge (1983), Minneapolis (1991), New Haven (1995), North Carolina (1999) and Japan (2005), and was also a member of Team Ontario at the National Games in Halifax (1994). Outside of competing, Arcangeletti has represented Special Olympics Ontario at the final leg of the Law Enforcement Torch Run for the 2001 World Winter Games in Anchorage, Alaska. He was also given the nod as male athlete of the year for Special Olympics Canada in 1996, and was officially inducted into the Sault Ste. Marie Sports Hall of Fame in 2007. Although numerous medals, ribbons and trophies adorn his home in the Sault, Arcangeletti remains adamant that all of the awards he’s won over the years are secondary in nature. “The accomplishments are your skills, your goals, the hard work you put into it,” he said.Trump Taps Sebastian Gorka as Senior Director for Counterterrorism: What’s His Stance on Ukraine?
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It’s a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It’s all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person’s response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn’t happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It’s not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn’t respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I’m hoping it’s slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.IoT Node and Gateway Market Opportunities and Competitive Strategies 2024-2031
Fourteen months after New Zealand smashed Italy 96-17 in Lyon, the All Blacks had to work much harder for their win against their European rivals after managing a hard-fought 29-11 win in Turin. In an ugly, scrappy performance, Scott Robertson’s side managed just a four-tries-to-one win after being tested at the breakdown on a bitterly cold night in Italy’s north-west. Credit had to go to Gonzalo Quesada’s side for their ability to make the last tackle and force the All Blacks into mistakes, but it was a game few will want to remember. “Probably their least convincing performance of the season,” former All Blacks winger Jeff Wilson said. “I think from an All Blacks perspective they’ll think of this as a frustrating day at the office.” Beauden Barrett scored a late try for the All Blacks in their unconvincing victory over Italy at the Allianz Stadium on November 23, 2024 in Turin. (Photo by Chris Ricco/Getty Images) Right from the opening whistle the All Blacks were off their game. Lock Patrick Tuipulotu put a boot onto the touchline from the opening kick-off, halfback Cam Roigard kicked out on the full from his first kick, while the Italians picked off Codie Taylor’s usual accurate throw. The mistakes continued, and the All Blacks only had themselves to blame after pushing passes and squandering try-scoring opportunities through impatience. “I think it really showed how much they wanted to beat us tonight through their intensity at the collision and the breakdown, so hats off to them. We were a little bit sloppy and probably weren’t up to our standards and how we want to play the game,” said captain Scott Barrett, who copped an early yellow card. “Greasy ball favoured defence at times, we hung in the arm-wrestle, we got in front and by no means was it a polished performance, but we come away with a win so it’s pleasing.” Sam Cane acknowledges the fans after making his final appearance for the All Blacks at the Allianz Stadium on November 23, 2024 in Turin. (Photo by Francesco Scaccianoce/Getty Images) The night saw the curtains drop on the international careers of World Cup winners Sam Cane and TJ Perenara, who will be ineligible to play for All Blacks moving forward after signing long-term deals in Japan. Their continued selections in 2024 raised eyebrows on the Shaky Isles, but Robertson spoke about their importance in laying down the law for the next generation of All Blacks after the retirements of several greats including Dane Coles, Sam Whitelock, Brodie Retallick and Aaron Smith over the past 14 months. “They’ve been great, particularly Sam,” Barrett said. “He’s a huge leader and he’s left a lot in this jersey. No man cares about this team more than him, so it’s great to see him off with a win and I want to wish him and TJ the best. “We came across some challenges this season, but we’ve won some tight Test matches, we’ve been in every Test match, the tough tour in South Africa, and we’ve come up north and wanted to emulate what the team did 100 years ago and go unbeaten and, unfortunately, we were one point short last week. We improved as the season went on and I’m pleased with the way this team is going.”Israel govt orders official boycott of critical newspaper, minister 'advocates a free press' but not 'incitement'
Nearly all of the 74 workers at Acrylicos Vallejo have gone on an indefinite strike. The popular Spanish paint company — which produces their Game Color and Model Color lines most popularly used in miniature painting and wargaming — first announced a partial strike in late November, but escalated earlier this week when they claimed Acrylicos Vallejo’s ownership would not negotiate with workers. According to a statement made on Bluesky by Catalonian labor organization CGT, the demands of the striking employees are threefold: a wage increase, an improvement of safety conditions, and protocols to handle workplace harassment. Incorporated in New Jersey in 1965, Acrylicos Vallejo moved to Barcelona, quickly becoming a major player in the European art scene for their vibrant and extensive color range before establishing themselves as a staple in the world of wargaming and miniatures. It currently distributes paints to over 55 countries across the globe. Following a trend of private capital consolidation, private equity firm Proa Capital purchased a majority stake in Acrylicos Vallejo for just under $53 million in December 2023. The worker’s strike comes in a parallel wave of global labor actions in nearly every sector including entertainment and gaming , most demanding higher wages and more protections in their respective industries. According to a statement by the CGT given to YouTuber Hellstorm Wargaming , workers at the Catalonian factory currently make around the Spanish minimum wage. Earlier this year, the Spanish Council of ministers raised the country’s minimum wage to €37.8 (just under $40) a day, or just over €1,134 ($1,200) a month — a roughly 50% increase from Spain’s minimum wage in 2018. Representatives from the CGT claim executive pay continues to grow with increased profits as employee wages stay stagnant. Workers are also calling for an improvement of safety conditions in the factory, which they allege to be in a “deplorable state.” In their statement they claim “Some parts of the ceiling have fallen, luckily without injuring anyone. There are outdated machines with no maintenance. To give you an idea, some machines had to be repaired by putting in brackets to keep them together.” Their final demand relates to workplace harassment, which they claim the company has no protocols to handle. “There are executives in the company who are professionals in workplace harassment, and have dedicated themselves to harassing and making workers’ lives impossible,” the CGT spokesperson alleged. Striking workers have not explicitly called for a boycott of Acrylicos Vallejo, but said “if you are considering not buying any more products until the strike is over, it will be a good way to put pressure on the company.” Many of the public responses to their strike announcement on social media have stated a refusal to purchase the company’s products until the demands are met. Acrylicos Vallejo has not made a public statement regarding the strike. Polygon did not immediately receive a response to a request for comment, and will update this article if one is provided. Gaming News Tabletop GamesFlorida Special Election Update as Mike Waltz to Resign
Ken Griffin is arguably one of the most successful investors of all time. He made a name for himself when he shorted stocks just ahead of the 1987 market crash that came to be known as "Black Monday." His profits last year topped $7 billion as his returns of roughly 15% outpaced many of his peers. That result pales in comparison to his performance in 2022, though, when Citadel became "the most successful hedge fund ever," according to CNN, generating profits of $16 billion, the "largest annual windfall on record." Griffin has been outspoken about the potential for generative AI . "This branch of AI will be game-changing for the economy," he said, "because it will take an enormous amount of work that's done today by people and do it in a distinctly different, highly automated, highly efficient way." These weren't just empty words. At the end of last year, Griffin's top five individual stock holdings were all AI companies. It's therefore worth noting that Griffin has sold more than half his stake in AI stock Broadcom ( AVGO 0.18% ) , and is pouring funds into another AI stock-split stock instead. Broadcom has been on fire Broadcom is one of the gatekeepers in the AI ecosystem . The company provides a wide range of products used in the cable, mobile, broadband, and data center industries. It reports that "99% of all internet traffic crosses through some type of Broadcom technology," making it a key provider of the tech necessary to facilitate AI. In its fiscal third quarter, which ended Aug. 4, Broadcom's revenue grew 47% year over year to $13.1 billion, while its adjusted earnings per share (EPS) increased 18% to $1.24. Management expects its growth streak to continue, and boosted its full-year revenue forecast to $51.5 billion, which would equate to growth of 44%. Those results help illustrate why Broadcom stock is up 64% over the past year and 188% over the past three years (at the time of this writing). The stock has risen so much, in fact, that management instituted a 10-for-1 stock split that was completed on July 15. Wall Street is nearly unanimous in its opinion of Broadcom. Of the 42 analysts who cover the stock, 37 rate it a buy or strong buy, and none recommend selling. That backdrop makes it all the more notable that, during the third quarter, Griffin sold more than 3.1 million shares of Broadcom -- roughly 64% of Citadel's stake in it. He still holds 1.72 million shares worth about $296 million. At the same time, he was buying another AI stock -- Nvidia ( NVDA -3.22% ) . Want chips with that? It's clear Griffin thought Nvidia represented a compelling opportunity last quarter. The billionaire investor increased Citadel's stake by more than 7 million shares, an increase of 454%. That brought his total stake to 712 million shares worth $865 million. Among the thousands of stocks in Citadel's portfolio, Nvidia is the second-largest individual stock holding. Nvidia has been the poster child for the AI revolution, as its graphics processing units (GPUs) are the most-used hardware for providing the computational horsepower needed to train and run AI models. This has caused a run on the company's state-of-the-art processors, which have become the gold standard for data centers, where most AI processing takes place. The unprecedented demand has had an unmistakable impact on Nvidia's financial results. During its fiscal 2025 third quarter, which ended Oct. 27, Nvidia's revenue soared 94% year over year to $35 billion, while its adjusted EPS surged 103% to $0.81. Management left no doubt about what drove the results. "The age of AI is in full steam, propelling a global shift to Nvidia computing," said CEO Jensen Huang. Those results help explain why Nvidia stock is up 196% over the past year and 342% over the past three years (as of this writing). The company's unbridled success led management to initiate a 10-for-1 stock split, which was completed on June 10. Broadcom isn't the only AI stock-split stock that Wall Street is nearly unanimous about. Of the 64 analysts who have offered an opinion on Nvidia, 60 rate the stock a buy or strong buy, and none recommend selling. We don't know exactly when during the third quarter that Griffin added to his stake in Nvidia, but a quick look at the stock chart might provide some insight. In mid-June, rumors about a potential delay in the release of the company's highly anticipated Blackwell processors sent the stock tumbling, and by early August, Nvidia had shed 27% of its value. Griffin likely saw a bargain he couldn't resist. It turns out that Griffin probably didn't know something that Wall Street doesn't. He simply saw a compelling opportunity, and he took it. Should retail investors follow his lead now? Nvidia stock currently trades for 69 times earnings, but that P/E metric doesn't take into account the company's above-average growth. Wall Street is predicting Nvidia will generate EPS of $4.36 in its fiscal 2026, which will begin in late January. That gives it a valuation of about 34 times forward earnings. While that's certainly still a premium price, Nvidia is guiding for year-over-year revenue growth of 70% in the current quarter, with a commensurate uptick in profits, and Wall Street is predicting sales growth of 49% next year. Given the company's critical place in the AI revolution and its robust prospects, I am completely convinced that Nvidia stock is still a buy .
None
Trump names billionaire investment banker Warren Stephens as his envoy to Britain
XRX Investors Have Opportunity to Lead Xerox Holdings Corporation Securities Fraud Lawsuit
None
EXCLUSIVE: David O. Sacks Productions, Mark Goffman and Getaway Entertainment are teaming to produce a feature-length film about Satoshi Nakamoto, the enigmatic founder of Bitcoin , with Sophia Banks set to direct. The movie, inspired by Andrew O’Hagan’s longform article “The Satoshi Affair,” will delve into the mystery surrounding the elusive creator of the world’s most revolutionary digital currency, blending investigative journalism with captivating storytelling. “This film will be akin to watching The Social Network without knowing who the Mark Zuckerberg character might actually be,” Sacks remarked. “I’m delighted that we have the correct team in place to bring O’Hagan’s investigation, and the events since that period, to life.” Producers David Sacks and Daniel Brunt optioned the article and took it to longtime collaborator Mark Goffman, who is adapting the screenplay and producing with Sacks and Brunt. Producing for Getaway Entertainment are Damiano Tucci, Banks and Arwen Elys Dayton. David Seimer is executive producing. The film will explore the dramatic events that led O’Hagan to investigate the mysterious figure known only as Satoshi Nakamoto, and his pursuit to uncover the true identity of the cryptic inventor behind Bitcoin. O’Hagan’s article was originally published in the London Review of Books as a long read and then published by Faber in the anthology The Secret Life . His first-person search for the truth takes readers on a journey through the technological innovation that has transformed the global financial system, along with the numerous eccentric and mercurial personalities he encountered. “We are so excited to be partnering with David, Daniel and Mark on this upcoming project,” said Tucci. “The story of Bitcoin’s creator is one that has captivated the world for years. We can’t wait to dive into one of the greatest modern-day mysteries and provide a deeper look into the world of cryptocurrency.” Goffman added, “What I love is that it isn’t another story about crypto fraudsters or even greed. This is the story of highly flawed, overlooked outsiders who rebelled against Wall Street in the wake of the 2008 financial crisis that took everything from them and millions of other people. And they’ve created a currency that has revolutionized the global financial industry.” Banks is known for her ability to blend gripping, character-driven narratives with thought-provoking themes. “The challenge of bringing such a complex story to life is one I am eager to take on,” said Banks, whose directing credits include the 2022 action thriller Black Site starring Michelle Monaghan, Jason Clarke and Jai Courtney. “This film will not only explore the question of ‘Who is Satoshi Nakamoto?’ but also the cultural and technological ripple effect that the creation of Bitcoin has had, and continues to have, on our world.” Getaway’s upcoming slate of projects includes the Cary Joji Fukunaga-helmed Blood on Snow starring Tom Hardy and Aaron Taylor-Johnson; Oh, Canada from Paul Schrader starring Richard Gere, Uma Thurman, Jacob Elordi and Michael Imperioli; Hand of Dante from Julian Schnabel with an ensemble cast including Gal Gadot, Oscar Isaac, Gerard Butler, Jason Momoa and Al Pacino; and The Luckiest Man In America starring Paul Walter Hauser, Walton Goggins, Maisie Williams, David Strathairn and Johnny Knoxville.
